Clover Health Investments, Corp., a prominent player in the U.S. health care sector, recently disclosed two significant shareholder-transaction filings on October 20, 2026. The company, which specializes in offering Medicare Advantage health plans, operates nationwide, providing hospital, medical, and private insurance services. As a publicly traded entity on the Nasdaq, Clover Health Investments, Corp. has a market capitalization of $2.54 billion, with its shares priced at $4.78 as of October 20, 2026.
The transactions involved two senior executives: Chief Legal Officer Karen Soares and CEO Jamie L. Reynoso. Both executives executed sales of Class A common shares under a Rule 10b5-1 trading plan. Karen Soares sold a modest block of shares, resulting in her holding approximately 1.6 million shares post-transaction. Similarly, Jamie L. Reynoso reduced her holdings to about 2.8 million shares following her sale. These transactions were conducted at prices within a narrow range, indicating stability in the company’s share price during this period.
In addition to these sales, Clover Health Investments, Corp. filed a Rule 144 notice earlier on the same day. This notice pertained to the sale of restricted stock units granted to Ms. Soares, providing details on the units’ vesting dates and the proceeds from the sale. These filings collectively highlight routine off-balance-sheet changes in shareholdings by senior executives and underscore the company’s adherence to SEC reporting requirements.
Clover Health Investments, Corp. has experienced significant share price fluctuations over the past year, with a 52-week high of $5.59 on June 28, 2026, and a low of $1.58 on March 31, 2026. Despite these variations, the company’s recent transactions reflect a stable share price environment. However, the company’s price-to-earnings ratio stands at -118.88, indicating challenges in profitability.
For investors and stakeholders interested in Clover Health Investments, Corp., further information about the company’s offerings and investment opportunities can be found on their website at www.cloverhealth.com . The company’s commitment to transparency and regulatory compliance is evident through its detailed reporting of executive transactions and adherence to SEC guidelines.
